Russia's pharma production grows despite sanctions and pressure from West

Pharmaceutical production in Russia in 2022 grew by more than 15% compared to 2021, while the industry continues to increase its technological independence, according to recent statements, by Russia’s Deputy Prime Minister Denis Manturov – a state official personally responsible for the development of pharmaceutical sector in the Russian government, reports The Pharma Letter’s local correspondent.

According to Mr Manturov, in recent years the Russian pharmaceutical industry has significantly expanded its capacities, competencies and product lines, while this trend was also observed in 2022.

As Mr Manturov and other senior Russian state officials in the field of pharmaceutics have said, domestic pharmaceutical companies are producing the necessary volumes of basic drugs and vaccines for the prevention and treatment of influenza and coronavirus, while “with an increase in demand, they will be able to quickly reconfigure their lines to especially demanded positions.”